147 related articles for article (PubMed ID: 9609125)
61. Overexpression of hexokinase II in transgenic mice. Evidence that increased phosphorylation augments muscle glucose uptake.
Chang PY; Jensen J; Printz RL; Granner DK; Ivy JL; Moller DE
J Biol Chem; 1996 Jun; 271(25):14834-9. PubMed ID: 8662926
[TBL] [Abstract][Full Text] [Related]
62. Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia.
Moller DE; Chang PY; Yaspelkis BB; Flier JS; Wallberg-Henriksson H; Ivy JL
Endocrinology; 1996 Jun; 137(6):2397-405. PubMed ID: 8641192
[TBL] [Abstract][Full Text] [Related]
63. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality.
Joshi RL; Lamothe B; Cordonnier N; Mesbah K; Monthioux E; Jami J; Bucchini D
EMBO J; 1996 Apr; 15(7):1542-7. PubMed ID: 8612577
[TBL] [Abstract][Full Text] [Related]
64. Insulin action impaired by deficiency of the G-protein subunit G ialpha2.
Moxham CM; Malbon CC
Nature; 1996 Feb; 379(6568):840-4. PubMed ID: 8587610
[TBL] [Abstract][Full Text] [Related]
65. Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose.
Terauchi Y; Sakura H; Yasuda K; Iwamoto K; Takahashi N; Ito K; Kasai H; Suzuki H; Ueda O; Kamada N
J Biol Chem; 1995 Dec; 270(51):30253-6. PubMed ID: 8530440
[TBL] [Abstract][Full Text] [Related]
66. Insulin stimulation of mitogen-activated protein kinase, p90rsk, and p70 S6 kinase in skeletal muscle of normal and insulin-resistant mice. Implications for the regulation of glycogen synthase.
Chang PY; Le Marchand-Brustel Y; Cheatham LA; Moller DE
J Biol Chem; 1995 Dec; 270(50):29928-35. PubMed ID: 8530392
[TBL] [Abstract][Full Text] [Related]
67. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene.
Accili D; Drago J; Lee EJ; Johnson MD; Cool MH; Salvatore P; Asico LD; José PA; Taylor SI; Westphal H
Nat Genet; 1996 Jan; 12(1):106-9. PubMed ID: 8528241
[No Abstract] [Full Text] [Related]
68. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle.
Tsao TS; Burcelin R; Katz EB; Huang L; Charron MJ
Diabetes; 1996 Jan; 45(1):28-36. PubMed ID: 8522056
[TBL] [Abstract][Full Text] [Related]
69. Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle.
Leturque A; Loizeau M; Vaulont S; Salminen M; Girard J
Diabetes; 1996 Jan; 45(1):23-7. PubMed ID: 8522055
[TBL] [Abstract][Full Text] [Related]
70. Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM).
Fox N; Schrementi J; Nishi M; Ohagi S; Chan SJ; Heisserman JA; Westermark GT; Leckström A; Westermark P; Steiner DF
FEBS Lett; 1993 May; 323(1-2):40-4. PubMed ID: 8495745
[TBL] [Abstract][Full Text] [Related]
71. Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice.
Olson AL; Liu ML; Moye-Rowley WS; Buse JB; Bell GI; Pessin JE
J Biol Chem; 1993 May; 268(13):9839-46. PubMed ID: 8486663
[TBL] [Abstract][Full Text] [Related]
72. Regulated expression of an insulin-responsive glucose transporter (GLUT4) minigene in 3T3-L1 adipocytes and transgenic mice.
Ezaki O; Flores-Riveros JR; Kaestner KH; Gearhart J; Lane MD
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3348-52. PubMed ID: 8475079
[TBL] [Abstract][Full Text] [Related]
73. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).
Liu JP; Baker J; Perkins AS; Robertson EJ; Efstratiadis A
Cell; 1993 Oct; 75(1):59-72. PubMed ID: 8402901
[TBL] [Abstract][Full Text] [Related]
74. Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle.
Marshall BA; Ren JM; Johnson DW; Gibbs EM; Lillquist JS; Soeller WC; Holloszy JO; Mueckler M
J Biol Chem; 1993 Sep; 268(25):18442-5. PubMed ID: 8360145
[TBL] [Abstract][Full Text] [Related]
75. Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle.
Ren JM; Marshall BA; Gulve EA; Gao J; Johnson DW; Holloszy JO; Mueckler M
J Biol Chem; 1993 Aug; 268(22):16113-5. PubMed ID: 8344895
[TBL] [Abstract][Full Text] [Related]
76. Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity.
Ross SR; Graves RA; Spiegelman BM
Genes Dev; 1993 Jul; 7(7B):1318-24. PubMed ID: 8330737
[TBL] [Abstract][Full Text] [Related]
77. Adaptation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of posttranscriptional regulation.
Schnetzler B; Murakawa G; Abalos D; Halban P; Selden R
J Clin Invest; 1993 Jul; 92(1):272-80. PubMed ID: 8325994
[TBL] [Abstract][Full Text] [Related]
78. IGF-I is required for normal embryonic growth in mice.
Powell-Braxton L; Hollingshead P; Warburton C; Dowd M; Pitts-Meek S; Dalton D; Gillett N; Stewart TA
Genes Dev; 1993 Dec; 7(12B):2609-17. PubMed ID: 8276243
[TBL] [Abstract][Full Text] [Related]
79. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue.
Lowell BB; S-Susulic V; Hamann A; Lawitts JA; Himms-Hagen J; Boyer BB; Kozak LP; Flier JS
Nature; 1993 Dec 23-30; 366(6457):740-2. PubMed ID: 8264795
[TBL] [Abstract][Full Text] [Related]
80. The diabetogenes concept of NIDDM.
De Meyts P
Adv Exp Med Biol; 1993; 334():89-100. PubMed ID: 8249698
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
